BIOMARKER:

RNF43 mutation

Entrez ID:

Related biomarkers:

‹

›

RNF43 mutation RNF43 mutation	Colorectal Cancer CRC	RNF43 mutation RNF43 mutation	Colorectal Cancer CRC	Immunotherapy Sensitive: C3 – Early Trials	Immunotherapy Sensitive: C3 – Early Trials
RNF43 mutation RNF43 mutation	Colorectal Cancer CRC	RNF43 mutation RNF43 mutation	Colorectal Cancer CRC	encorafenib Sensitive: C3 – Early Trials	encorafenib Sensitive: C3 – Early Trials
RNF43 mutation RNF43 mutation	Colorectal Cancer CRC	RNF43 mutation RNF43 mutation	Colorectal Cancer CRC	cetuximab + alpelisib + encorafenib Sensitive: C3 – Early Trials	cetuximab + alpelisib + encorafenib Sensitive: C3 – Early Trials
RNF43 mutation RNF43 mutation	Bladder Cancer Bladder Cancer	RNF43 mutation RNF43 mutation	Bladder Cancer Bladder Cancer	Immunotherapy Sensitive: C3 – Early Trials	Immunotherapy Sensitive: C3 – Early Trials
RNF43 mutation RNF43 mutation	Pancreatic Ductal Adenocarcinoma Pancreatic Ductal Adenocarcinoma	RNF43 mutation RNF43 mutation	Pancreatic Ductal Adenocarcinoma Pancreatic Ductal Adenocarcinoma	avelumab + binimetinib Sensitive: C3 – Early Trials	avelumab + binimetinib Sensitive: C3 – Early Trials
RNF43 mutation RNF43 mutation	Colorectal Cancer CRC	RNF43 mutation RNF43 mutation	Colorectal Cancer CRC	PORCN inhibitor Sensitive: D – Preclinical	PORCN inhibitor Sensitive: D – Preclinical